IDEA4RC FHIR Implementation Guide
0.1.0 - CI Build
150
IDEA4RC FHIR Implementation Guide
0.1.0 - CI Build
150
IDEA4RC FHIR Implementation Guide, published by IDEA4RC Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/idea4rc/ and changes regularly. See the Directory of published versions
| Draft as of 2025-05-06 |
Definitions for the Subject logical model.
Guidance on how to interpret the contents of this table can be found here
| 0. Subject | |||||||||
| Definition | Subject of care. Maturity Level: 0 Draft | ||||||||
| Short | Patient | ||||||||
| Control | 0..* | ||||||||
| Is Modifier | false | ||||||||
| Logical Model | Instances of this logical model are not marked to be the target of a Reference | ||||||||
| 2. Subject.sex | |||||||||
| Definition | Describes biological sex as recorded in the patient's identity document or in the hospital record. In the absence of documentation, the one declared by the patient will be recorded | ||||||||
| Short | Sex (M) | ||||||||
| Comments | Male - 8507 Female - 8532 | ||||||||
| Control | 1..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 4. Subject.race | |||||||||
| Definition | Describes race as recorded in the hospital record, the one declared by the patient,, otherwise, the onerecognized by the observer privacy issues for registering race in France. Hispanic is present only in BB. Hispanic is not mapped as race. If Hispanic, OMOP race=0, if not, OMOP ethnicity= 38003564 If "hispanic" register ethnicity, otherwise register race | ||||||||
| Short | Race (M) | ||||||||
| Comments | White - 8527 Black - 8516 Asian/Pacific Islanders - 8515 American Indian/Alaska Native - 8657 Hispanic or Latino - 38003563 | ||||||||
| Control | 1..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 6. Subject.birthYear | |||||||||
| Definition | Year of birth of the patient. PERSON.year_of_birth | ||||||||
| Short | Birth year (M) | ||||||||
| Control | 1..* | ||||||||
| Type | integer | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 8. Subject.countryOfResidence | |||||||||
| Definition | Country of residence at the time of diagnosis | ||||||||
| Short | Country of Residence (M) | ||||||||
| Comments | Son in the hierarchy of countries | ||||||||
| Control | 1..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 10. Subject.smoking | |||||||||
| Definition | Describes tobacco smoker habits within the options proposed Changed vocabulary codes to be standard (BLUEBERRY was not) | ||||||||
| Short | Smoking (M) | ||||||||
| Comments | Current smoker - 36309332 Former smoker - 45883458 Never smoker - 45879404 | ||||||||
| Control | 1..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 12. Subject.cigarettesPackYearsSmokedDuringLife | |||||||||
| Definition | Calculates pack/ year by multiplying the number of packs of cigarettes smoked per day by the number of years the person has been smoking. Register the actual value of pack/years in the value_as_number field | ||||||||
| Short | Cigarettes pack years smoked during life (R) | ||||||||
| Control | 0..* | ||||||||
| Type | integer | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 14. Subject.alcohol | |||||||||
| Definition | Describes alcohol habits within the options proposed | ||||||||
| Short | Alcohol (M) | ||||||||
| Comments | Current drinker - 4074035 Ex-drinker - 4220362 Lifetime non-drinker of alcohol - 37204556 Ex-problem drinker - 4117706 | ||||||||
| Control | 1..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 16. Subject.bmi | |||||||||
| Definition | Body Mass Index information if weight and height are included. it is calculated as BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in metres squared. Register the actual value of BMI centile in the value_as_number field | ||||||||
| Short | Height/weight (BMI) (R) | ||||||||
| Control | 0..* | ||||||||
| Type | Quantity | ||||||||
| Obligations |
| ||||||||
| 18. Subject.charlsonComorbidityIndex | |||||||||
| Definition | Provides the Charlson Comorbidity index for the patient | ||||||||
| Short | Charlson Comorbidity index (R) | ||||||||
| Control | 0..* | ||||||||
| Type | integer | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 20. Subject.comorbidity | |||||||||
| Definition | Describes wherther the patient was diagnosed before treatment of at least one of the comorbidities listed or not. It refers to any disease or medical condition that is simultaneously present with the cancer under study. | ||||||||
| Short | Comorbidity (M) | ||||||||
| Control | 1..* | ||||||||
| Type | BackboneElement | ||||||||
| Obligations |
| ||||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) | ||||||||
| 22. Subject.comorbidity.id | |||||||||
| Definition | Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces. | ||||||||
| Short | Unique id for inter-element referencing | ||||||||
| Control | 0..1 | ||||||||
| Type | string | ||||||||
| Is Modifier | false | ||||||||
| XML Format | In the XML format, this property is represented as an attribute. | ||||||||
| Summary | false | ||||||||
| 24. Subject.comorbidity.extension | |||||||||
| Definition | May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. | ||||||||
| Short | Additional content defined by implementations | ||||||||
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. | ||||||||
| Control | 0..* | ||||||||
| Type | Extension | ||||||||
| Is Modifier | false | ||||||||
| Summary | false | ||||||||
| Alternate Names | extensions, user content | ||||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) ext-1: Must have either extensions or value[x], not both (extension.exists() != value.exists()) | ||||||||
| Slicing | This element introduces a set of slices on Subject.comorbidity.extension. The slices areUnordered and Open, and can be differentiated using the following discriminators: | ||||||||
| 26. Subject.comorbidity.modifierExtension | |||||||||
| Definition | May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself). | ||||||||
| Short | Extensions that cannot be ignored even if unrecognized | ||||||||
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. | ||||||||
| Control | 0..* | ||||||||
| Type | Extension | ||||||||
| Is Modifier | true because Modifier extensions are expected to modify the meaning or interpretation of the element that contains them | ||||||||
| Summary | true | ||||||||
| Requirements | Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions. | ||||||||
| Alternate Names | extensions, user content, modifiers | ||||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) ext-1: Must have either extensions or value[x], not both (extension.exists() != value.exists()) | ||||||||
| 28. Subject.comorbidity.myocardialInfarction | |||||||||
| Definition | Describes comorbidities reported or assesed before treatment. More than one choice is allowed. Please do not include the current cancer in this calculation, only the previous cancer. | ||||||||
| Short | Myocardial infarction (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 30. Subject.comorbidity.congestiveHeartFailure | |||||||||
| Definition | Previous cancer comorbidity related to Congestive heart failure | ||||||||
| Short | Congestive heart failure (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 32. Subject.comorbidity.peripheralVascularDisease | |||||||||
| Definition | Previous cancer comorbidity related to Peripheral vascular disease | ||||||||
| Short | Peripheral vascular disease (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 34. Subject.comorbidity.cerebrovascularAccidentExceptHemiplegia | |||||||||
| Definition | Previous cancer comorbidity related to Cerebrovascular accident (except hemiplegia) | ||||||||
| Short | Cerebrovascular accident (except hemiplegia) (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 36. Subject.comorbidity.dementia | |||||||||
| Definition | Previous cancer comorbidity related to Dementia | ||||||||
| Short | Dementia (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 38. Subject.comorbidity.chronicPulmonaryDisease | |||||||||
| Definition | Previous cancer comorbidity related to Chronic pulmonary disease | ||||||||
| Short | Chronic pulmonary disease (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 40. Subject.comorbidity.connectiveTissueDisease | |||||||||
| Definition | Previous cancer comorbidity related to Connective tissue disease | ||||||||
| Short | Connective tissue disease (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 42. Subject.comorbidity.ulcer | |||||||||
| Definition | Previous cancer comorbidity related to Ulcer Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 | ||||||||
| Short | Ulcer (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 44. Subject.comorbidity.mildLiverDisease | |||||||||
| Definition | Previous cancer comorbidity related to Mild liver disease | ||||||||
| Short | Mild liver disease (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 46. Subject.comorbidity.moderateToSevereLiverDisease | |||||||||
| Definition | Previous cancer comorbidity related to Moderate to severe liver disease Same as Moderate to severe renal disease | ||||||||
| Short | Moderate to severe liver disease (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 48. Subject.comorbidity.diabetes | |||||||||
| Definition | Previous cancer comorbidity related to Diabetes (without complications) | ||||||||
| Short | Diabetes (without complications) (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 50. Subject.comorbidity.diabetesWithEndOrganDamage | |||||||||
| Definition | Previous cancer comorbidity related to Diabetes with end organ damage | ||||||||
| Short | Diabetes with end organ damage (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 52. Subject.comorbidity.hemiplegia | |||||||||
| Definition | Previous cancer comorbidity related to Hemiplegia Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 | ||||||||
| Short | Hemiplegia (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 54. Subject.comorbidity.moderateToSevereRenalDisease | |||||||||
| Definition | Previous cancer comorbidity related to Moderate to severe renal disease Same as Moderate to severe liver disease | ||||||||
| Short | Moderate to severe renal disease (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 56. Subject.comorbidity.solidTumor | |||||||||
| Definition | Previous cancer comorbidity related to Solid tumor (non metastatic) History of event + Other cancer (find the corresponding standard concept) Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 IT NEEDS TO BE PRESENTED | ||||||||
| Short | Solid tumor (non metastatic) (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 58. Subject.comorbidity.metastaticSolidTumor | |||||||||
| Definition | Previous cancer comorbidity related to Metastatic solid tumor History of event + Other cancer (find the corresponding standard concept) | ||||||||
| Short | Metastatic solid tumor (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 60. Subject.comorbidity.leukemia | |||||||||
| Definition | Previous cancer comorbidity related to Leukemia History of event + Leukemia Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 | ||||||||
| Short | Leukemia (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 62. Subject.comorbidity.lymphoma | |||||||||
| Definition | Previous cancer comorbidity related to Lymphoma History of event + Malignant Lymphoma NOS Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 | ||||||||
| Short | Lymphoma (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 64. Subject.comorbidity.multipleMyeloma | |||||||||
| Definition | Previous cancer comorbidity related to Multiple myeloma History of event + Multiple myeloma Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 | ||||||||
| Short | Multiple myeloma (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 66. Subject.comorbidity.aids | |||||||||
| Definition | Previous cancer comorbidity related to AIDS History of event + AIDS | ||||||||
| Short | AIDS (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 68. Subject.ecogPsAtDiagnosis | |||||||||
| Definition | Eastern Cooperative Oncology Group performance status (ECOG PS) at diagnosis | ||||||||
| Short | Eastern Cooperative Oncology Group performance status (ECOG PS) at diagnosis (R) | ||||||||
| Control | 0..* | ||||||||
| Type | integer | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 70. Subject.ecogPsLabel | |||||||||
| Definition | Eastern Cooperative Oncology Group performance status (ECOG PS) at diagnosis | ||||||||
| Short | ECOG PS label (R) | ||||||||
| Comments | Answers of ECOG Performance Status [Interpretation] - 36303470 | ||||||||
| Control | 0..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 72. Subject.karnofsyIndexAtDiagnosis | |||||||||
| Definition | Karnofsy index at diagnosis. Consider only the first KI before any treatment available in the clinical record. | ||||||||
| Short | Karnofsy index at diagnosis (R) | ||||||||
| Control | 0..* | ||||||||
| Type | integer | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 74. Subject.karnofsyIndexLabel | |||||||||
| Definition | Karnofsy index at diagnosis. Consider only the first KI before any treatment available in the clinical record. | ||||||||
| Short | Karnofsy index label (R) | ||||||||
| Comments | Answers of Karnofsky Performance Status [Interpretation] - 36303744 | ||||||||
| Control | 0..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 76. Subject.noGeneticSyndromeWho2020 | |||||||||
| Definition | If no genetic syndrome was identified for the patient. based on WHO 2020. use 37204336 [Genetic disease] as value_as_concept_id | ||||||||
| Short | No Genetic syndrome (M) | ||||||||
| Comments | No evidence of - 4211787 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) | ||||||||
| 78. Subject.noGeneticSyndromeWho2020.id | |||||||||
| Definition | unique id for the element within a resource (for internal references) Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces. | ||||||||
| Short | xml:id (or equivalent in JSON)Unique id for inter-element referencing | ||||||||
| Control | 0..1 | ||||||||
| Type | string | ||||||||
| Is Modifier | false | ||||||||
| XML Format | In the XML format, this property is represented as an attribute. | ||||||||
| Summary | false | ||||||||
| 80. Subject.noGeneticSyndromeWho2020.extension | |||||||||
| Definition | May be used to represent additional information that is not part of the basic definition of the resource. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. | ||||||||
| Short | Additional content defined by implementations | ||||||||
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. | ||||||||
| Control | 0..* | ||||||||
| Type | Extension | ||||||||
| Is Modifier | false | ||||||||
| Summary | false | ||||||||
| Alternate Names | extensions, user content | ||||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) ext-1: Must have either extensions or value[x], not both ( extension.exists() != value.exists())ext-1: Must have either extensions or value[x], not both (extension.exists() != value.exists()) | ||||||||
| 82. Subject.noGeneticSyndromeWho2020.value | |||||||||
| Definition | The actual value | ||||||||
| Short | Primitive value for boolean | ||||||||
| Control | 0..1 | ||||||||
| Type | boolean | ||||||||
| Is Modifier | false | ||||||||
| XML Format | In the XML format, this property is represented as an attribute. | ||||||||
| Summary | false | ||||||||
| 84. Subject.noGeneticSyndromeWho2020.olliersDisease | |||||||||
| Definition | If patient presents Olliers disease | ||||||||
| Short | Olliers disease (M) | ||||||||
| Comments | Enchondromatosis - 4145177 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 86. Subject.noGeneticSyndromeWho2020.maffuciSyndrome | |||||||||
| Definition | If patient presents Maffuci syndrome | ||||||||
| Short | Maffuci syndrome (M) | ||||||||
| Comments | Maffucci syndrome - 4187683 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 88. Subject.noGeneticSyndromeWho2020.liFraumeniSyndrome | |||||||||
| Definition | If patient presents Li-Fraumeni syndrome | ||||||||
| Short | Li-Fraumeni syndrome (M) | ||||||||
| Comments | Li-Fraumeni syndrome - 4323645 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 90. Subject.noGeneticSyndromeWho2020.mcCuneAlbrightSyndrome | |||||||||
| Definition | If patient presents McCune-Albright syndrome | ||||||||
| Short | McCune-Albright syndrome (M) | ||||||||
| Comments | McCune Albright syndrome - 37117262 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 92. Subject.noGeneticSyndromeWho2020.multipleOsteochondromas | |||||||||
| Definition | If patient presents Multiple osteochondromas | ||||||||
| Short | Multiple osteochondromas (M) | ||||||||
| Comments | Multiple osteochondroma - 37396802 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 94. Subject.noGeneticSyndromeWho2020.neurofibromatosisType1 | |||||||||
| Definition | If patient presents Neurofibromatosis type 1 | ||||||||
| Short | Neurofibromatosis type 1 (M) | ||||||||
| Comments | Neurofibromatosis type 1 - 377252 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 96. Subject.noGeneticSyndromeWho2020.rothmundThomsonSyndrome | |||||||||
| Definition | If patient presents Rothmund-Thomson syndrome | ||||||||
| Short | Rothmund-Thomson syndrome (M) | ||||||||
| Comments | Rothmund-Thomson syndrome - 4286355 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 98. Subject.noGeneticSyndromeWho2020.wernerSyndrome | |||||||||
| Definition | If patient presents Werner syndrome | ||||||||
| Short | Werner syndrome (M) | ||||||||
| Comments | Werner syndrome - 4197821 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 100. Subject.noGeneticSyndromeWho2020.retinoblastoma | |||||||||
| Definition | If patient presents Retinoblastoma | ||||||||
| Short | Retinoblastoma (M) | ||||||||
| Comments | Retinoblastoma - 4158977 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 102. Subject.noGeneticSyndromeWho2020.pagetDisease | |||||||||
| Definition | If patient presents Paget disease | ||||||||
| Short | Paget disease (M) | ||||||||
| Comments | Osteitis deformans - 75910 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 104. Subject.noGeneticSyndromeWho2020.otherSyndromes | |||||||||
| Definition | If patient presents Other Genetic syndrome. According to WHO 2020 History of event + Other genetic syndrome (find the corresponding standard concept) If not specified, use 37204336 [Genetic disease] | ||||||||
| Short | Other Genetic syndrome (M) | ||||||||
| Comments | History of event - 1340204
| ||||||||
| Control | 1..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 106. Subject.previousMalignantCancerSite | |||||||||
| Definition | Describes the site of the malignant tumour reported or assesed before the cancer under study. Any type of of solid and haematological cancer is listed. To obtain the previous malignant cancer refer to the solid tumor (metastatic and non-metastatic) comorbidity History of event + Cancer modifier for site | ||||||||
| Short | Previous malignant cancer site (R) | ||||||||
| Comments | Values from CancerModifier Topography Use integer for IDEA4RC if needed | ||||||||
| Control | 0..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 108. Subject.previousCancerTreatment | |||||||||
| Definition | Describes the type of treatment performed for the previous cancer History of event + Other treatment (find the corresponding standard concept) If not specified, | ||||||||
| Short | Previous cancer treatment (M) | ||||||||
| Comments | Chemotherapy - 4273629 Radiation oncology- 4170755 Surgery - 4121697 Comprehensive medication therapy review - 42535584 Immunological therapy - 4295112 | ||||||||
| Control | 1..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
Guidance on how to interpret the contents of this table can be found here
| 0. Subject | |||||||
| Definition | Subject of care. Maturity Level: 0 Draft | ||||||
| Short | Patient | ||||||
| Logical Model | Instances of this logical model are not marked to be the target of a Reference | ||||||
| 2. Subject.sex | |||||||
| Definition | Describes biological sex as recorded in the patient's identity document or in the hospital record. In the absence of documentation, the one declared by the patient will be recorded | ||||||
| Short | Sex (M) | ||||||
| Comments | Male - 8507 Female - 8532 | ||||||
| Control | 1..* | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 4. Subject.race | |||||||
| Definition | Describes race as recorded in the hospital record, the one declared by the patient,, otherwise, the onerecognized by the observer privacy issues for registering race in France. Hispanic is present only in BB. Hispanic is not mapped as race. If Hispanic, OMOP race=0, if not, OMOP ethnicity= 38003564 If "hispanic" register ethnicity, otherwise register race | ||||||
| Short | Race (M) | ||||||
| Comments | White - 8527 Black - 8516 Asian/Pacific Islanders - 8515 American Indian/Alaska Native - 8657 Hispanic or Latino - 38003563 | ||||||
| Control | 1..* | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 6. Subject.birthYear | |||||||
| Definition | Year of birth of the patient. PERSON.year_of_birth | ||||||
| Short | Birth year (M) | ||||||
| Control | 1..* | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 8. Subject.countryOfResidence | |||||||
| Definition | Country of residence at the time of diagnosis | ||||||
| Short | Country of Residence (M) | ||||||
| Comments | Son in the hierarchy of countries | ||||||
| Control | 1..* | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 10. Subject.smoking | |||||||
| Definition | Describes tobacco smoker habits within the options proposed Changed vocabulary codes to be standard (BLUEBERRY was not) | ||||||
| Short | Smoking (M) | ||||||
| Comments | Current smoker - 36309332 Former smoker - 45883458 Never smoker - 45879404 | ||||||
| Control | 1..* | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 12. Subject.cigarettesPackYearsSmokedDuringLife | |||||||
| Definition | Calculates pack/ year by multiplying the number of packs of cigarettes smoked per day by the number of years the person has been smoking. Register the actual value of pack/years in the value_as_number field | ||||||
| Short | Cigarettes pack years smoked during life (R) | ||||||
| Control | 0..* | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 14. Subject.alcohol | |||||||
| Definition | Describes alcohol habits within the options proposed | ||||||
| Short | Alcohol (M) | ||||||
| Comments | Current drinker - 4074035 Ex-drinker - 4220362 Lifetime non-drinker of alcohol - 37204556 Ex-problem drinker - 4117706 | ||||||
| Control | 1..* | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 16. Subject.bmi | |||||||
| Definition | Body Mass Index information if weight and height are included. it is calculated as BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in metres squared. Register the actual value of BMI centile in the value_as_number field | ||||||
| Short | Height/weight (BMI) (R) | ||||||
| Control | 0..* | ||||||
| Type | Quantity | ||||||
| Obligations |
| ||||||
| 18. Subject.charlsonComorbidityIndex | |||||||
| Definition | Provides the Charlson Comorbidity index for the patient | ||||||
| Short | Charlson Comorbidity index (R) | ||||||
| Control | 0..* | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 20. Subject.comorbidity | |||||||
| Definition | Describes wherther the patient was diagnosed before treatment of at least one of the comorbidities listed or not. It refers to any disease or medical condition that is simultaneously present with the cancer under study. | ||||||
| Short | Comorbidity (M) | ||||||
| Control | 1..* | ||||||
| Type | BackboneElement | ||||||
| Obligations |
| ||||||
| 22. Subject.comorbidity.myocardialInfarction | |||||||
| Definition | Describes comorbidities reported or assesed before treatment. More than one choice is allowed. Please do not include the current cancer in this calculation, only the previous cancer. | ||||||
| Short | Myocardial infarction (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 24. Subject.comorbidity.congestiveHeartFailure | |||||||
| Definition | Previous cancer comorbidity related to Congestive heart failure | ||||||
| Short | Congestive heart failure (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 26. Subject.comorbidity.peripheralVascularDisease | |||||||
| Definition | Previous cancer comorbidity related to Peripheral vascular disease | ||||||
| Short | Peripheral vascular disease (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 28. Subject.comorbidity.cerebrovascularAccidentExceptHemiplegia | |||||||
| Definition | Previous cancer comorbidity related to Cerebrovascular accident (except hemiplegia) | ||||||
| Short | Cerebrovascular accident (except hemiplegia) (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 30. Subject.comorbidity.dementia | |||||||
| Definition | Previous cancer comorbidity related to Dementia | ||||||
| Short | Dementia (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 32. Subject.comorbidity.chronicPulmonaryDisease | |||||||
| Definition | Previous cancer comorbidity related to Chronic pulmonary disease | ||||||
| Short | Chronic pulmonary disease (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 34. Subject.comorbidity.connectiveTissueDisease | |||||||
| Definition | Previous cancer comorbidity related to Connective tissue disease | ||||||
| Short | Connective tissue disease (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 36. Subject.comorbidity.ulcer | |||||||
| Definition | Previous cancer comorbidity related to Ulcer Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 | ||||||
| Short | Ulcer (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 38. Subject.comorbidity.mildLiverDisease | |||||||
| Definition | Previous cancer comorbidity related to Mild liver disease | ||||||
| Short | Mild liver disease (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 40. Subject.comorbidity.moderateToSevereLiverDisease | |||||||
| Definition | Previous cancer comorbidity related to Moderate to severe liver disease Same as Moderate to severe renal disease | ||||||
| Short | Moderate to severe liver disease (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 42. Subject.comorbidity.diabetes | |||||||
| Definition | Previous cancer comorbidity related to Diabetes (without complications) | ||||||
| Short | Diabetes (without complications) (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 44. Subject.comorbidity.diabetesWithEndOrganDamage | |||||||
| Definition | Previous cancer comorbidity related to Diabetes with end organ damage | ||||||
| Short | Diabetes with end organ damage (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 46. Subject.comorbidity.hemiplegia | |||||||
| Definition | Previous cancer comorbidity related to Hemiplegia Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 | ||||||
| Short | Hemiplegia (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 48. Subject.comorbidity.moderateToSevereRenalDisease | |||||||
| Definition | Previous cancer comorbidity related to Moderate to severe renal disease Same as Moderate to severe liver disease | ||||||
| Short | Moderate to severe renal disease (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 50. Subject.comorbidity.solidTumor | |||||||
| Definition | Previous cancer comorbidity related to Solid tumor (non metastatic) History of event + Other cancer (find the corresponding standard concept) Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 IT NEEDS TO BE PRESENTED | ||||||
| Short | Solid tumor (non metastatic) (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 52. Subject.comorbidity.metastaticSolidTumor | |||||||
| Definition | Previous cancer comorbidity related to Metastatic solid tumor History of event + Other cancer (find the corresponding standard concept) | ||||||
| Short | Metastatic solid tumor (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 54. Subject.comorbidity.leukemia | |||||||
| Definition | Previous cancer comorbidity related to Leukemia History of event + Leukemia Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 | ||||||
| Short | Leukemia (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 56. Subject.comorbidity.lymphoma | |||||||
| Definition | Previous cancer comorbidity related to Lymphoma History of event + Malignant Lymphoma NOS Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 | ||||||
| Short | Lymphoma (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 58. Subject.comorbidity.multipleMyeloma | |||||||
| Definition | Previous cancer comorbidity related to Multiple myeloma History of event + Multiple myeloma Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 | ||||||
| Short | Multiple myeloma (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 60. Subject.comorbidity.aids | |||||||
| Definition | Previous cancer comorbidity related to AIDS History of event + AIDS | ||||||
| Short | AIDS (O) | ||||||
| Control | 0..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 62. Subject.ecogPsAtDiagnosis | |||||||
| Definition | Eastern Cooperative Oncology Group performance status (ECOG PS) at diagnosis | ||||||
| Short | Eastern Cooperative Oncology Group performance status (ECOG PS) at diagnosis (R) | ||||||
| Control | 0..* | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 64. Subject.ecogPsLabel | |||||||
| Definition | Eastern Cooperative Oncology Group performance status (ECOG PS) at diagnosis | ||||||
| Short | ECOG PS label (R) | ||||||
| Comments | Answers of ECOG Performance Status [Interpretation] - 36303470 | ||||||
| Control | 0..* | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 66. Subject.karnofsyIndexAtDiagnosis | |||||||
| Definition | Karnofsy index at diagnosis. Consider only the first KI before any treatment available in the clinical record. | ||||||
| Short | Karnofsy index at diagnosis (R) | ||||||
| Control | 0..* | ||||||
| Type | integer | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 68. Subject.karnofsyIndexLabel | |||||||
| Definition | Karnofsy index at diagnosis. Consider only the first KI before any treatment available in the clinical record. | ||||||
| Short | Karnofsy index label (R) | ||||||
| Comments | Answers of Karnofsky Performance Status [Interpretation] - 36303744 | ||||||
| Control | 0..* | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 70. Subject.noGeneticSyndromeWho2020 | |||||||
| Definition | If no genetic syndrome was identified for the patient. based on WHO 2020. use 37204336 [Genetic disease] as value_as_concept_id | ||||||
| Short | No Genetic syndrome (M) | ||||||
| Comments | No evidence of - 4211787 | ||||||
| Control | 1..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 72. Subject.noGeneticSyndromeWho2020.olliersDisease | |||||||
| Definition | If patient presents Olliers disease | ||||||
| Short | Olliers disease (M) | ||||||
| Comments | Enchondromatosis - 4145177 | ||||||
| Control | 1..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 74. Subject.noGeneticSyndromeWho2020.maffuciSyndrome | |||||||
| Definition | If patient presents Maffuci syndrome | ||||||
| Short | Maffuci syndrome (M) | ||||||
| Comments | Maffucci syndrome - 4187683 | ||||||
| Control | 1..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 76. Subject.noGeneticSyndromeWho2020.liFraumeniSyndrome | |||||||
| Definition | If patient presents Li-Fraumeni syndrome | ||||||
| Short | Li-Fraumeni syndrome (M) | ||||||
| Comments | Li-Fraumeni syndrome - 4323645 | ||||||
| Control | 1..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 78. Subject.noGeneticSyndromeWho2020.mcCuneAlbrightSyndrome | |||||||
| Definition | If patient presents McCune-Albright syndrome | ||||||
| Short | McCune-Albright syndrome (M) | ||||||
| Comments | McCune Albright syndrome - 37117262 | ||||||
| Control | 1..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 80. Subject.noGeneticSyndromeWho2020.multipleOsteochondromas | |||||||
| Definition | If patient presents Multiple osteochondromas | ||||||
| Short | Multiple osteochondromas (M) | ||||||
| Comments | Multiple osteochondroma - 37396802 | ||||||
| Control | 1..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 82. Subject.noGeneticSyndromeWho2020.neurofibromatosisType1 | |||||||
| Definition | If patient presents Neurofibromatosis type 1 | ||||||
| Short | Neurofibromatosis type 1 (M) | ||||||
| Comments | Neurofibromatosis type 1 - 377252 | ||||||
| Control | 1..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 84. Subject.noGeneticSyndromeWho2020.rothmundThomsonSyndrome | |||||||
| Definition | If patient presents Rothmund-Thomson syndrome | ||||||
| Short | Rothmund-Thomson syndrome (M) | ||||||
| Comments | Rothmund-Thomson syndrome - 4286355 | ||||||
| Control | 1..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 86. Subject.noGeneticSyndromeWho2020.wernerSyndrome | |||||||
| Definition | If patient presents Werner syndrome | ||||||
| Short | Werner syndrome (M) | ||||||
| Comments | Werner syndrome - 4197821 | ||||||
| Control | 1..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 88. Subject.noGeneticSyndromeWho2020.retinoblastoma | |||||||
| Definition | If patient presents Retinoblastoma | ||||||
| Short | Retinoblastoma (M) | ||||||
| Comments | Retinoblastoma - 4158977 | ||||||
| Control | 1..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 90. Subject.noGeneticSyndromeWho2020.pagetDisease | |||||||
| Definition | If patient presents Paget disease | ||||||
| Short | Paget disease (M) | ||||||
| Comments | Osteitis deformans - 75910 | ||||||
| Control | 1..* | ||||||
| Type | boolean | ||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||
| Obligations |
| ||||||
| 92. Subject.noGeneticSyndromeWho2020.otherSyndromes | |||||||
| Definition | If patient presents Other Genetic syndrome. According to WHO 2020 History of event + Other genetic syndrome (find the corresponding standard concept) If not specified, use 37204336 [Genetic disease] | ||||||
| Short | Other Genetic syndrome (M) | ||||||
| Comments | History of event - 1340204
| ||||||
| Control | 1..* | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 94. Subject.previousMalignantCancerSite | |||||||
| Definition | Describes the site of the malignant tumour reported or assesed before the cancer under study. Any type of of solid and haematological cancer is listed. To obtain the previous malignant cancer refer to the solid tumor (metastatic and non-metastatic) comorbidity History of event + Cancer modifier for site | ||||||
| Short | Previous malignant cancer site (R) | ||||||
| Comments | Values from CancerModifier Topography Use integer for IDEA4RC if needed | ||||||
| Control | 0..* | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
| 96. Subject.previousCancerTreatment | |||||||
| Definition | Describes the type of treatment performed for the previous cancer History of event + Other treatment (find the corresponding standard concept) If not specified, | ||||||
| Short | Previous cancer treatment (M) | ||||||
| Comments | Chemotherapy - 4273629 Radiation oncology- 4170755 Surgery - 4121697 Comprehensive medication therapy review - 42535584 Immunological therapy - 4295112 | ||||||
| Control | 1..* | ||||||
| Type | CodeableConcept | ||||||
| Obligations |
| ||||||
Guidance on how to interpret the contents of this table can be found here
| 0. Subject | |||||||||
| Definition | Subject of care. Maturity Level: 0 Draft | ||||||||
| Short | Patient | ||||||||
| Control | 0..* | ||||||||
| Is Modifier | false | ||||||||
| Logical Model | Instances of this logical model are not marked to be the target of a Reference | ||||||||
| 2. Subject.sex | |||||||||
| Definition | Describes biological sex as recorded in the patient's identity document or in the hospital record. In the absence of documentation, the one declared by the patient will be recorded | ||||||||
| Short | Sex (M) | ||||||||
| Comments | Male - 8507 Female - 8532 | ||||||||
| Control | 1..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 4. Subject.race | |||||||||
| Definition | Describes race as recorded in the hospital record, the one declared by the patient,, otherwise, the onerecognized by the observer privacy issues for registering race in France. Hispanic is present only in BB. Hispanic is not mapped as race. If Hispanic, OMOP race=0, if not, OMOP ethnicity= 38003564 If "hispanic" register ethnicity, otherwise register race | ||||||||
| Short | Race (M) | ||||||||
| Comments | White - 8527 Black - 8516 Asian/Pacific Islanders - 8515 American Indian/Alaska Native - 8657 Hispanic or Latino - 38003563 | ||||||||
| Control | 1..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 6. Subject.birthYear | |||||||||
| Definition | Year of birth of the patient. PERSON.year_of_birth | ||||||||
| Short | Birth year (M) | ||||||||
| Control | 1..* | ||||||||
| Type | integer | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 8. Subject.countryOfResidence | |||||||||
| Definition | Country of residence at the time of diagnosis | ||||||||
| Short | Country of Residence (M) | ||||||||
| Comments | Son in the hierarchy of countries | ||||||||
| Control | 1..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 10. Subject.smoking | |||||||||
| Definition | Describes tobacco smoker habits within the options proposed Changed vocabulary codes to be standard (BLUEBERRY was not) | ||||||||
| Short | Smoking (M) | ||||||||
| Comments | Current smoker - 36309332 Former smoker - 45883458 Never smoker - 45879404 | ||||||||
| Control | 1..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 12. Subject.cigarettesPackYearsSmokedDuringLife | |||||||||
| Definition | Calculates pack/ year by multiplying the number of packs of cigarettes smoked per day by the number of years the person has been smoking. Register the actual value of pack/years in the value_as_number field | ||||||||
| Short | Cigarettes pack years smoked during life (R) | ||||||||
| Control | 0..* | ||||||||
| Type | integer | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 14. Subject.alcohol | |||||||||
| Definition | Describes alcohol habits within the options proposed | ||||||||
| Short | Alcohol (M) | ||||||||
| Comments | Current drinker - 4074035 Ex-drinker - 4220362 Lifetime non-drinker of alcohol - 37204556 Ex-problem drinker - 4117706 | ||||||||
| Control | 1..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 16. Subject.bmi | |||||||||
| Definition | Body Mass Index information if weight and height are included. it is calculated as BMI = kg/m2 where kg is a person's weight in kilograms and m2 is their height in metres squared. Register the actual value of BMI centile in the value_as_number field | ||||||||
| Short | Height/weight (BMI) (R) | ||||||||
| Control | 0..* | ||||||||
| Type | Quantity | ||||||||
| Obligations |
| ||||||||
| 18. Subject.charlsonComorbidityIndex | |||||||||
| Definition | Provides the Charlson Comorbidity index for the patient | ||||||||
| Short | Charlson Comorbidity index (R) | ||||||||
| Control | 0..* | ||||||||
| Type | integer | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 20. Subject.comorbidity | |||||||||
| Definition | Describes wherther the patient was diagnosed before treatment of at least one of the comorbidities listed or not. It refers to any disease or medical condition that is simultaneously present with the cancer under study. | ||||||||
| Short | Comorbidity (M) | ||||||||
| Control | 1..* | ||||||||
| Type | BackboneElement | ||||||||
| Obligations |
| ||||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) | ||||||||
| 22. Subject.comorbidity.id | |||||||||
| Definition | Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces. | ||||||||
| Short | Unique id for inter-element referencing | ||||||||
| Control | 0..1 | ||||||||
| Type | string | ||||||||
| Is Modifier | false | ||||||||
| XML Format | In the XML format, this property is represented as an attribute. | ||||||||
| Summary | false | ||||||||
| 24. Subject.comorbidity.extension | |||||||||
| Definition | May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. | ||||||||
| Short | Additional content defined by implementations | ||||||||
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. | ||||||||
| Control | 0..* | ||||||||
| Type | Extension | ||||||||
| Is Modifier | false | ||||||||
| Summary | false | ||||||||
| Alternate Names | extensions, user content | ||||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count()))ext-1: Must have either extensions or value[x], not both ( extension.exists() != value.exists()) | ||||||||
| Slicing | This element introduces a set of slices on Subject.comorbidity.extension. The slices areUnordered and Open, and can be differentiated using the following discriminators: | ||||||||
| 26. Subject.comorbidity.modifierExtension | |||||||||
| Definition | May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained and/or the understanding of the containing element's descendants. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions. Modifier extensions SHALL NOT change the meaning of any elements on Resource or DomainResource (including cannot change the meaning of modifierExtension itself). | ||||||||
| Short | Extensions that cannot be ignored even if unrecognized | ||||||||
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. | ||||||||
| Control | 0..* | ||||||||
| Type | Extension | ||||||||
| Is Modifier | true because Modifier extensions are expected to modify the meaning or interpretation of the element that contains them | ||||||||
| Summary | true | ||||||||
| Requirements | Modifier extensions allow for extensions that cannot be safely ignored to be clearly distinguished from the vast majority of extensions which can be safely ignored. This promotes interoperability by eliminating the need for implementers to prohibit the presence of extensions. For further information, see the definition of modifier extensions. | ||||||||
| Alternate Names | extensions, user content, modifiers | ||||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count()))ext-1: Must have either extensions or value[x], not both ( extension.exists() != value.exists()) | ||||||||
| 28. Subject.comorbidity.myocardialInfarction | |||||||||
| Definition | Describes comorbidities reported or assesed before treatment. More than one choice is allowed. Please do not include the current cancer in this calculation, only the previous cancer. | ||||||||
| Short | Myocardial infarction (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 30. Subject.comorbidity.congestiveHeartFailure | |||||||||
| Definition | Previous cancer comorbidity related to Congestive heart failure | ||||||||
| Short | Congestive heart failure (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 32. Subject.comorbidity.peripheralVascularDisease | |||||||||
| Definition | Previous cancer comorbidity related to Peripheral vascular disease | ||||||||
| Short | Peripheral vascular disease (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 34. Subject.comorbidity.cerebrovascularAccidentExceptHemiplegia | |||||||||
| Definition | Previous cancer comorbidity related to Cerebrovascular accident (except hemiplegia) | ||||||||
| Short | Cerebrovascular accident (except hemiplegia) (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 36. Subject.comorbidity.dementia | |||||||||
| Definition | Previous cancer comorbidity related to Dementia | ||||||||
| Short | Dementia (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 38. Subject.comorbidity.chronicPulmonaryDisease | |||||||||
| Definition | Previous cancer comorbidity related to Chronic pulmonary disease | ||||||||
| Short | Chronic pulmonary disease (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 40. Subject.comorbidity.connectiveTissueDisease | |||||||||
| Definition | Previous cancer comorbidity related to Connective tissue disease | ||||||||
| Short | Connective tissue disease (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 42. Subject.comorbidity.ulcer | |||||||||
| Definition | Previous cancer comorbidity related to Ulcer Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 | ||||||||
| Short | Ulcer (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 44. Subject.comorbidity.mildLiverDisease | |||||||||
| Definition | Previous cancer comorbidity related to Mild liver disease | ||||||||
| Short | Mild liver disease (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 46. Subject.comorbidity.moderateToSevereLiverDisease | |||||||||
| Definition | Previous cancer comorbidity related to Moderate to severe liver disease Same as Moderate to severe renal disease | ||||||||
| Short | Moderate to severe liver disease (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 48. Subject.comorbidity.diabetes | |||||||||
| Definition | Previous cancer comorbidity related to Diabetes (without complications) | ||||||||
| Short | Diabetes (without complications) (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 50. Subject.comorbidity.diabetesWithEndOrganDamage | |||||||||
| Definition | Previous cancer comorbidity related to Diabetes with end organ damage | ||||||||
| Short | Diabetes with end organ damage (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 52. Subject.comorbidity.hemiplegia | |||||||||
| Definition | Previous cancer comorbidity related to Hemiplegia Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 | ||||||||
| Short | Hemiplegia (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 54. Subject.comorbidity.moderateToSevereRenalDisease | |||||||||
| Definition | Previous cancer comorbidity related to Moderate to severe renal disease Same as Moderate to severe liver disease | ||||||||
| Short | Moderate to severe renal disease (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 56. Subject.comorbidity.solidTumor | |||||||||
| Definition | Previous cancer comorbidity related to Solid tumor (non metastatic) History of event + Other cancer (find the corresponding standard concept) Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 IT NEEDS TO BE PRESENTED | ||||||||
| Short | Solid tumor (non metastatic) (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 58. Subject.comorbidity.metastaticSolidTumor | |||||||||
| Definition | Previous cancer comorbidity related to Metastatic solid tumor History of event + Other cancer (find the corresponding standard concept) | ||||||||
| Short | Metastatic solid tumor (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 60. Subject.comorbidity.leukemia | |||||||||
| Definition | Previous cancer comorbidity related to Leukemia History of event + Leukemia Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 | ||||||||
| Short | Leukemia (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 62. Subject.comorbidity.lymphoma | |||||||||
| Definition | Previous cancer comorbidity related to Lymphoma History of event + Malignant Lymphoma NOS Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 | ||||||||
| Short | Lymphoma (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 64. Subject.comorbidity.multipleMyeloma | |||||||||
| Definition | Previous cancer comorbidity related to Multiple myeloma History of event + Multiple myeloma Couldnt find it under https://athena.ohdsi.org/search-terms/terms/46235351 | ||||||||
| Short | Multiple myeloma (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 66. Subject.comorbidity.aids | |||||||||
| Definition | Previous cancer comorbidity related to AIDS History of event + AIDS | ||||||||
| Short | AIDS (O) | ||||||||
| Control | 0..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 68. Subject.ecogPsAtDiagnosis | |||||||||
| Definition | Eastern Cooperative Oncology Group performance status (ECOG PS) at diagnosis | ||||||||
| Short | Eastern Cooperative Oncology Group performance status (ECOG PS) at diagnosis (R) | ||||||||
| Control | 0..* | ||||||||
| Type | integer | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 70. Subject.ecogPsLabel | |||||||||
| Definition | Eastern Cooperative Oncology Group performance status (ECOG PS) at diagnosis | ||||||||
| Short | ECOG PS label (R) | ||||||||
| Comments | Answers of ECOG Performance Status [Interpretation] - 36303470 | ||||||||
| Control | 0..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 72. Subject.karnofsyIndexAtDiagnosis | |||||||||
| Definition | Karnofsy index at diagnosis. Consider only the first KI before any treatment available in the clinical record. | ||||||||
| Short | Karnofsy index at diagnosis (R) | ||||||||
| Control | 0..* | ||||||||
| Type | integer | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 74. Subject.karnofsyIndexLabel | |||||||||
| Definition | Karnofsy index at diagnosis. Consider only the first KI before any treatment available in the clinical record. | ||||||||
| Short | Karnofsy index label (R) | ||||||||
| Comments | Answers of Karnofsky Performance Status [Interpretation] - 36303744 | ||||||||
| Control | 0..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 76. Subject.noGeneticSyndromeWho2020 | |||||||||
| Definition | If no genetic syndrome was identified for the patient. based on WHO 2020. use 37204336 [Genetic disease] as value_as_concept_id | ||||||||
| Short | No Genetic syndrome (M) | ||||||||
| Comments | No evidence of - 4211787 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count())) | ||||||||
| 78. Subject.noGeneticSyndromeWho2020.id | |||||||||
| Definition | unique id for the element within a resource (for internal references) | ||||||||
| Short | xml:id (or equivalent in JSON) | ||||||||
| Control | 0..1 | ||||||||
| Type | string | ||||||||
| Is Modifier | false | ||||||||
| XML Format | In the XML format, this property is represented as an attribute. | ||||||||
| Summary | false | ||||||||
| 80. Subject.noGeneticSyndromeWho2020.extension | |||||||||
| Definition | May be used to represent additional information that is not part of the basic definition of the resource. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. | ||||||||
| Short | Additional content defined by implementations | ||||||||
| Comments | There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone. | ||||||||
| Control | 0..* | ||||||||
| Type | Extension | ||||||||
| Is Modifier | false | ||||||||
| Summary | false | ||||||||
| Alternate Names | extensions, user content | ||||||||
| Invariants | ele-1: All FHIR elements must have a @value or children (hasValue() or (children().count() > id.count()))ext-1: Must have either extensions or value[x], not both ( extension.exists() != value.exists()) | ||||||||
| 82. Subject.noGeneticSyndromeWho2020.value | |||||||||
| Definition | The actual value | ||||||||
| Short | Primitive value for boolean | ||||||||
| Control | 0..1 | ||||||||
| Type | boolean | ||||||||
| Is Modifier | false | ||||||||
| XML Format | In the XML format, this property is represented as an attribute. | ||||||||
| Summary | false | ||||||||
| 84. Subject.noGeneticSyndromeWho2020.olliersDisease | |||||||||
| Definition | If patient presents Olliers disease | ||||||||
| Short | Olliers disease (M) | ||||||||
| Comments | Enchondromatosis - 4145177 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 86. Subject.noGeneticSyndromeWho2020.maffuciSyndrome | |||||||||
| Definition | If patient presents Maffuci syndrome | ||||||||
| Short | Maffuci syndrome (M) | ||||||||
| Comments | Maffucci syndrome - 4187683 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 88. Subject.noGeneticSyndromeWho2020.liFraumeniSyndrome | |||||||||
| Definition | If patient presents Li-Fraumeni syndrome | ||||||||
| Short | Li-Fraumeni syndrome (M) | ||||||||
| Comments | Li-Fraumeni syndrome - 4323645 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 90. Subject.noGeneticSyndromeWho2020.mcCuneAlbrightSyndrome | |||||||||
| Definition | If patient presents McCune-Albright syndrome | ||||||||
| Short | McCune-Albright syndrome (M) | ||||||||
| Comments | McCune Albright syndrome - 37117262 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 92. Subject.noGeneticSyndromeWho2020.multipleOsteochondromas | |||||||||
| Definition | If patient presents Multiple osteochondromas | ||||||||
| Short | Multiple osteochondromas (M) | ||||||||
| Comments | Multiple osteochondroma - 37396802 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 94. Subject.noGeneticSyndromeWho2020.neurofibromatosisType1 | |||||||||
| Definition | If patient presents Neurofibromatosis type 1 | ||||||||
| Short | Neurofibromatosis type 1 (M) | ||||||||
| Comments | Neurofibromatosis type 1 - 377252 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 96. Subject.noGeneticSyndromeWho2020.rothmundThomsonSyndrome | |||||||||
| Definition | If patient presents Rothmund-Thomson syndrome | ||||||||
| Short | Rothmund-Thomson syndrome (M) | ||||||||
| Comments | Rothmund-Thomson syndrome - 4286355 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 98. Subject.noGeneticSyndromeWho2020.wernerSyndrome | |||||||||
| Definition | If patient presents Werner syndrome | ||||||||
| Short | Werner syndrome (M) | ||||||||
| Comments | Werner syndrome - 4197821 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 100. Subject.noGeneticSyndromeWho2020.retinoblastoma | |||||||||
| Definition | If patient presents Retinoblastoma | ||||||||
| Short | Retinoblastoma (M) | ||||||||
| Comments | Retinoblastoma - 4158977 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 102. Subject.noGeneticSyndromeWho2020.pagetDisease | |||||||||
| Definition | If patient presents Paget disease | ||||||||
| Short | Paget disease (M) | ||||||||
| Comments | Osteitis deformans - 75910 | ||||||||
| Control | 1..* | ||||||||
| Type | boolean | ||||||||
| Primitive Value | This primitive element may be present, or absent, or replaced by an extension | ||||||||
| Obligations |
| ||||||||
| 104. Subject.noGeneticSyndromeWho2020.otherSyndromes | |||||||||
| Definition | If patient presents Other Genetic syndrome. According to WHO 2020 History of event + Other genetic syndrome (find the corresponding standard concept) If not specified, use 37204336 [Genetic disease] | ||||||||
| Short | Other Genetic syndrome (M) | ||||||||
| Comments | History of event - 1340204
| ||||||||
| Control | 1..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 106. Subject.previousMalignantCancerSite | |||||||||
| Definition | Describes the site of the malignant tumour reported or assesed before the cancer under study. Any type of of solid and haematological cancer is listed. To obtain the previous malignant cancer refer to the solid tumor (metastatic and non-metastatic) comorbidity History of event + Cancer modifier for site | ||||||||
| Short | Previous malignant cancer site (R) | ||||||||
| Comments | Values from CancerModifier Topography Use integer for IDEA4RC if needed | ||||||||
| Control | 0..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
| 108. Subject.previousCancerTreatment | |||||||||
| Definition | Describes the type of treatment performed for the previous cancer History of event + Other treatment (find the corresponding standard concept) If not specified, | ||||||||
| Short | Previous cancer treatment (M) | ||||||||
| Comments | Chemotherapy - 4273629 Radiation oncology- 4170755 Surgery - 4121697 Comprehensive medication therapy review - 42535584 Immunological therapy - 4295112 | ||||||||
| Control | 1..* | ||||||||
| Type | CodeableConcept | ||||||||
| Obligations |
| ||||||||
IG © 2022+ IDEA4RC Project. Package hl7.eu.fhir.idea4rc#0.1.0 based on FHIR 4.0.1. Generated 2025-05-06
Links: Table of Contents |
QA Report
The IDEA4RC project has received funding from the European Union's Horizon 2020
research and innovation programme under grant agreement No. 101057048.
